NASDAQ · Key Statistics

Innate Pharma S.A. (IPHA) Key Statistics

$1.79 NASDAQ: IPHA Market Cap $168.32M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Innate Pharma S.A. (IPHA), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-2.89
P/B ratioShare price divided by book value per share.	-6.70
P/S ratioMarket value divided by annual revenue.	53.57
PEG ratioP/E divided by the earnings growth rate.	-0.29
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-2.57
EV / RevenueEnterprise value against annual revenue.	17.37
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-34.60%
Free cash flow yieldFree cash flow as a percentage of market value.	-35.43%
Price / free cash flowMarket value divided by free cash flow.	-2.82

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	100.00%
Operating marginRevenue left after operating costs.	-689.55%
Net marginRevenue left after every cost, including tax and interest.	-1633.33%
Return on equityProfit as a percentage of shareholders’ equity.	593.93%
Return on assetsProfit as a percentage of total assets.	-78.41%
Return on capital employedOperating profit against the capital the business uses.	-220.01%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	1.27
Quick ratioThe same, excluding inventory.	1.27
Cash ratioCash alone against current liabilities.	0.76
Debt to equityTotal borrowings against shareholders’ equity.	-1.04
Debt to assetsTotal borrowings against total assets.	0.37
Interest coverageHow many times operating profit covers the interest bill.	-18.38

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-0.53
Book value per shareShareholders’ equity divided by shares outstanding.	$-0.24
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$168.32M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$163.32M

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Innate Pharma S.A. (IPHA) statistics — frequently asked questions

What is Innate Pharma S.A.'s P/E ratio?

Innate Pharma S.A. (IPHA) trades on a price-to-earnings ratio of -2.89. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Innate Pharma S.A.'s return on equity?

Innate Pharma S.A. (IPHA) reports a return on equity of 593.93%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Innate Pharma S.A. carry?

Innate Pharma S.A. (IPHA) has a debt-to-equity ratio of -1.04, which compares total borrowings with shareholders' equity.

What is Innate Pharma S.A.'s profit margin?

Innate Pharma S.A. (IPHA) keeps -1633.33% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.